pharmaphorum

SEPTEMBER 30, 2022

Genetic testing has become vastly more accessible in the last 20 years and has opened all kinds of doors in medicine, from pharmacogenetics and better understanding drug interactions and adverse events to tremendous advances in oncology: understanding the underlying genetics of cancer cells has allowed delivery of affective, targeted treatments.

Behavioural Health 98

Behavioural Health Genetics Medicine Drugs 98

pharmaphorum

DECEMBER 16, 2022

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Generative AI drug creation company Absci Corporation has added Dan Rabinovitsj (as pictured), VP of connectivity at Meta, to its Board of Directors. Digital therapeutics hires.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

pharmaphorum

OCTOBER 2, 2020

“Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

Behavioural Health 98

Behavioural Health Production FDA Approval Pharma Production 98

Drug Discovery World

JANUARY 12, 2023

In January 2022, DDW’s Megan Thomas spoke to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector. This one element of the predictions made by Cooper, shows how much is going on concurrently in the drug discovery industry.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97